- Report
- October 2024
- 70 Pages
Latin America
From €838EUR$950USD£734GBP
- Report
- October 2025
- 84 Pages
Oman
From €4279EUR$4,850USD£3,747GBP
- Report
- October 2025
- 90 Pages
Kuwait
From €4279EUR$4,850USD£3,747GBP
- Report
- October 2025
- 88 Pages
Bahrain
From €4279EUR$4,850USD£3,747GBP
- Report
- July 2025
- 63 Pages
Brazil, China, India, ... Brazil, China, India, Russia
From €5289EUR$5,995USD£4,631GBP
- Report
- June 2025
- 30 Pages
Canada
From €4407EUR$4,995USD£3,859GBP
- Report
- June 2025
- 27 Pages
Germany
From €4407EUR$4,995USD£3,859GBP
- Report
- June 2025
- 27 Pages
India
From €4407EUR$4,995USD£3,859GBP
- Report
- June 2025
- 28 Pages
Australia
From €4407EUR$4,995USD£3,859GBP
- Report
- December 2024
- 436 Pages
Global
From €3529EUR$4,000USD£3,090GBP
- Report
- August 2024
- 112 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- August 2024
- 62 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- August 2024
- 189 Pages
Global
From €3529EUR$4,000USD£3,090GBP
- Report
- July 2024
- 127 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- February 2024
- 48 Pages
Global
From €2206EUR$2,500USD£1,931GBP
- Report
- November 2023
- 76 Pages
Global
From €3970EUR$4,500USD£3,476GBP
- Report
- February 2023
- 183 Pages
From €3044EUR$3,450USD£2,665GBP
- Report
- November 2022
- 150 Pages
Global
From €4279EUR$4,850USD£3,747GBP
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more